BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28132100)

  • 21. [Clinical, biochemical and immunological characteristic of diabetes type I, LADA, diabetes type II, and MODY patients].
    Szepietowska B; Szelachowska M; Górska M; Stepień A; Kinalska I
    Pol Arch Med Wewn; 2002 Dec; 108(6):1177-84. PubMed ID: 12687930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [MODY type diabetes: overview and recent findings].
    Ben Khelifa S; Barboura I; Dandana A; Ferchichi S; Miled A
    Ann Biol Clin (Paris); 2011; 69(5):531-40. PubMed ID: 22008132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How do I diagnose Maturity Onset Diabetes of the Young in my patients?
    Colclough K; Patel K
    Clin Endocrinol (Oxf); 2022 Oct; 97(4):436-447. PubMed ID: 35445424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of appropriate biochemical parameters and cut points to detect Maturity Onset Diabetes of Young (MODY) in Asian Indians in a clinic setting.
    Aarthy R; Aston-Mourney K; Amutha A; Mikocka-Walus A; Anjana RM; Unnikrishnan R; Jebarani S; Venkatesan U; Gopi S; Radha V; Mohan V
    Sci Rep; 2023 Jul; 13(1):11408. PubMed ID: 37452084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing maturity-onset diabetes of the young detection in a pediatric diabetes population.
    Menon S; Refaey A; Guffey D; Balasubramanyam A; Redondo MJ; Tosur M
    Pediatr Diabetes; 2022 Jun; 23(4):447-456. PubMed ID: 35218126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
    Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kuwahara H; Kobayashi M; Abiru N; Yamasaki H; Eguchi K
    J Clin Endocrinol Metab; 2010 Feb; 95(2):707-13. PubMed ID: 20061424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Maturity onset diabetes of the young: just think about it].
    Messaaoui A; Tenoutasse S; Dorchy H
    Rev Med Brux; 2016; 37(2):95-100. PubMed ID: 27487694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience from a regional monogenic diabetes referral centre in Singapore.
    Ang SF; Tan CSH; Chan LWT; Goh LX; Kon WYC; Lian JX; Subramanium T; Sum CF; Lim SC
    Diabetes Res Clin Pract; 2020 Oct; 168():108390. PubMed ID: 32858097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mature onset diabetes of the young (MODY)].
    Nobre EL; Lopes LO; Miranda A; Pragosa M; de Castro JJ
    Acta Med Port; 2002; 15(6):435-9. PubMed ID: 12680290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review on monogenic diabetes.
    Steck AK; Winter WE
    Curr Opin Endocrinol Diabetes Obes; 2011 Aug; 18(4):252-8. PubMed ID: 21844708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incremental cost-effectiveness of algorithm-driven genetic testing versus no testing for Maturity Onset Diabetes of the Young (MODY) in Singapore.
    Nguyen HV; Finkelstein EA; Mital S; Gardner DS
    J Med Genet; 2017 Nov; 54(11):747-753. PubMed ID: 28835481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Optimization of monogenic diabetes screening programme--initial report on recruitment efficacy of the TEAM project].
    Borowiec M; Fendler W; Antosik K; Ciepiela A; Baranowska A; Hogendorf A; Mianowska B; Szadkowska A; Młynarski W
    Pediatr Endocrinol Diabetes Metab; 2010; 16(2):73-6. PubMed ID: 20813082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monogenic diabetes in a family with 2 unknown HNF-4A gene mutations.
    Motzkau M; Meyer P; Mertens PR; Klose S
    Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):89-90. PubMed ID: 21922456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and molecular characterization of a novel INS mutation identified in patients with MODY phenotype.
    Piccini B; Artuso R; Lenzi L; Guasti M; Braccesi G; Barni F; Casalini E; Giglio S; Toni S
    Eur J Med Genet; 2016 Nov; 59(11):590-595. PubMed ID: 27659712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The coexistence of type 1 diabetes, MODY2 and metabolic syndrome in a young girl.
    Calcaterra V; Martinetti M; Salina A; Aloi C; Larizza D
    Acta Diabetol; 2012 Oct; 49(5):401-4. PubMed ID: 21688019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maturity onset diabetes of the young (MODY)--history, first case reports and recent advances.
    Siddiqui K; Musambil M; Nazir N
    Gene; 2015 Jan; 555(1):66-71. PubMed ID: 25281821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of novel variants in the hepatocyte nuclear factor 4A gene with maturity onset diabetes of the young and early onset type 2 diabetes.
    Anuradha S; Radha V; Mohan V
    Clin Genet; 2011 Dec; 80(6):541-9. PubMed ID: 21062274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Searching for Maturity-Onset Diabetes of the Young (MODY): When and What for?
    Timsit J; Saint-Martin C; Dubois-Laforgue D; Bellanné-Chantelot C
    Can J Diabetes; 2016 Oct; 40(5):455-461. PubMed ID: 27103109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical application of non-genetic biomarkers for differential diagnosis of monogenic diabetes.
    Owen KR; Skupien J; Malecki MT;
    Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S15-21. PubMed ID: 20115926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic testing for misclassified monogenic diabetes in Māori and Pacific peoples in Aōtearoa New Zealand with early-onset type 2 diabetes.
    Toomata Z; Leask M; Krishnan M; Cadzow M; Dalbeth N; Stamp LK; de Zoysa J; Merriman T; Wilcox P; Dewes O; Murphy R
    Front Endocrinol (Lausanne); 2023; 14():1174699. PubMed ID: 37234800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.